Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2026-03-22 @ 10:00 AM
Study NCT ID:
NCT00260702
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2005-12-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Omalizumab to Treat Hyper-IgE (Job's) Syndrome
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-11-24
Start Date Type:
None
Primary Completion Date:
2010-03-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-03-19
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-01
First Submit QC Date:
None
Study First Post Date:
2005-12-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-30
Last Update Post Date:
2017-07-02
Last Update Post Date Type:
ACTUAL